Pages that link to "Q45036102"
Jump to navigation
Jump to search
The following pages link to Prednisolone decreases cellular adhesion molecules required for inflammatory cell infiltration in dystrophin-deficient skeletal muscle (Q45036102):
Displaying 39 items.
- Osteopontin promotes fibrosis in dystrophic mouse muscle by modulating immune cell subsets and intramuscular TGF-beta (Q24652960) (← links)
- Diseased muscles that lack dystrophin or laminin-alpha2 have altered compositions and proliferation of mononuclear cell populations (Q24791491) (← links)
- Duchenne Muscular Dystrophy: From Diagnosis to Therapy (Q26784259) (← links)
- IRES-mediated translation of utrophin A is enhanced by glucocorticoid treatment in skeletal muscle cells (Q28472887) (← links)
- Pregnancy-induced amelioration of muscular dystrophy phenotype in mdx mice via muscle membrane stabilization effect of glucocorticoid (Q28544401) (← links)
- Arginine metabolism by macrophages promotes cardiac and muscle fibrosis in mdx muscular dystrophy (Q33588636) (← links)
- Regulatory interactions between muscle and the immune system during muscle regeneration (Q33841066) (← links)
- Effects of prednisolone on skeletal muscle contractility in mdx mice (Q33887318) (← links)
- Matrix metalloproteinase inhibitor batimastat alleviates pathology and improves skeletal muscle function in dystrophin-deficient mdx mice (Q33947243) (← links)
- Neuronal Nitric Oxide Synthase-Rescue of Dystrophin/Utrophin Double Knockout Mice does not Require nNOS Localization to the Cell Membrane (Q34049251) (← links)
- Pharmacologic management of Duchenne muscular dystrophy: target identification and preclinical trials (Q34152280) (← links)
- Interleukin-10 reduces the pathology of mdx muscular dystrophy by deactivating M1 macrophages and modulating macrophage phenotype (Q34505654) (← links)
- IFN-γ Promotes Muscle Damage in the mdx Mouse Model of Duchenne Muscular Dystrophy by Suppressing M2 Macrophage Activation and Inhibiting Muscle Cell Proliferation (Q35523128) (← links)
- The immune system in Duchenne muscular dystrophy: Friend or foe. (Q36105761) (← links)
- Therapy insight: cardiovascular complications associated with muscular dystrophies (Q36304335) (← links)
- Regulatory T cells suppress muscle inflammation and injury in muscular dystrophy (Q36957496) (← links)
- Implications of cross-talk between tumour necrosis factor and insulin-like growth factor-1 signalling in skeletal muscle. (Q37063632) (← links)
- Shifts in macrophage phenotypes and macrophage competition for arginine metabolism affect the severity of muscle pathology in muscular dystrophy (Q37090043) (← links)
- Wasting mechanisms in muscular dystrophy. (Q37138490) (← links)
- Gene therapy in large animal models of muscular dystrophy (Q37396408) (← links)
- Protein-DNA array-based identification of transcription factor activities differentially regulated in skeletal muscle of normal and dystrophin-deficient mdx mice. (Q37447128) (← links)
- A high-content, high-throughput siRNA screen identifies cyclin D2 as a potent regulator of muscle progenitor cell fusion and a target to enhance muscle regeneration (Q37464145) (← links)
- Mechanisms of muscle injury, repair, and regeneration (Q38111732) (← links)
- What has the mdx mouse model of Duchenne muscular dystrophy contributed to our understanding of this disease? (Q38351283) (← links)
- Andrographolide attenuates skeletal muscle dystrophy in mdx mice and increases efficiency of cell therapy by reducing fibrosis (Q39629598) (← links)
- Motor performance of young dystrophic mdx mice treated with long-circulating prednisolone liposomes (Q39663447) (← links)
- Treatment with human immunoglobulin G improves the early disease course in a mouse model of Duchenne muscular dystrophy (Q41527279) (← links)
- Flt-1 haploinsufficiency ameliorates muscular dystrophy phenotype by developmentally increased vasculature in mdx mice (Q42067795) (← links)
- From innate to adaptive immune response in muscular dystrophies and skeletal muscle regeneration: the role of lymphocytes (Q42071747) (← links)
- Relationship between Leukopenia and Intercellular Adhesion Molecules in Graves' Disease (Q42161525) (← links)
- Intermittent glucocorticoid steroid dosing enhances muscle repair without eliciting muscle atrophy. (Q42234763) (← links)
- Upregulation of paxillin and focal adhesion signaling follows Dystroglycan Complex deletions and promotes a hypertensive state of differentiation (Q42386051) (← links)
- Steroid therapy is associated with decreased numbers of dendritic cells and fibroblasts, and increased numbers of satellite cells, in the dystrophic skeletal muscle (Q42916320) (← links)
- Targeting early PKCθ-dependent T-cell infiltration of dystrophic muscle reduces disease severity in a mouse model of muscular dystrophy. (Q47320981) (← links)
- The effects of glucocorticoid therapy on the inflammatory and dendritic cells in muscular dystrophies (Q61989402) (← links)
- Local injections of adipose-derived mesenchymal stem cells modulate inflammation and increase angiogenesis ameliorating the dystrophic phenotype in dystrophin-deficient skeletal muscle (Q84847497) (← links)
- Screening ginseng saponins in progenitor cells identifies 20(R)-ginsenoside Rh2 as an enhancer of skeletal and cardiac muscle regeneration (Q90438864) (← links)
- Immunobiology of Inherited Muscular Dystrophies (Q91446266) (← links)
- Dystrophin deficiency promotes leukocyte recruitment in mdx mice (Q92041371) (← links)